TG Therapeutics Q1 2026 Earnings EPS Disappoints as Stock Declines IPDN Q2 2023 Earnings Net Loss of 014 Per Share Reflects Ongoing Investment Phase CRIS Q1 2026 Earnings Significant EPS Miss as Biotech Advances Pipeline Without Revenue MDLN Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response EH Q4 2025 Earnings Massive EPS Surprise as Profitability Arrives Heidmar Maritime Holdings Corp HMR Q4 2025 Earnings Significant EPS Miss Amidst Operational Headwinds